For Immediate Release: March 18, 2015

Mary Kuramoto
513-579-9911 x2523

Medpace Launches “The Power of Giving” Campaign Program aligns with therapeutically-focused clinical research model

CINCINNATI, OH — (March 18, 2015) – Medpace is introducing a year-long “The Power of Giving” campaign that aligns with the company’s key therapeutic and specialty areas in which it designs and executes clinical trials for drug, biologic and medical device sponsors. Launching at the 24th annual Partnerships in Clinical Trials Conference April 22-24 in Boston, Medpace will invite conference attendees stop by booth 417 to “choose a charity” to which a $5 contribution will be made. A maximum of $5000 will be donated to each charity at the end of the year.

The six charities include:

“The Power of Giving campaign lets people directly participate in the company’s mission to accelerate the global development of safe and effective medical therapeutics, while also bringing attention to the key therapeutic and specialty areas where we have deep expertise and experience,” explained Todd Meyers, Vice-President Business Development at Medpace. “Rather than giving out the typical branded items at conferences, we believe participants will appreciate the opportunity to support a charity that helps fund important clinical research and support patients and families afflicted with disease.”

Medpace offers a unique physician-driven approach to clinical research. By embedding medical, scientific, and regulatory expertise throughout trial design and execution, Medpace has earned a reputation for adeptly managing complex and challenging clinical studies. The company shares its unique 20+-year history and approach to clinical research through its “Power of X: Experts, Experience and Execution” campaign.

The Power of Giving Campaign will continue throughout the year at conferences such as DIA and others where Medpace is a sponsor.

Designate a donation online: For more information, or to choose a charity to receive a $5 contribution, visit this page. Your votes will be tallied for the year-end contribution to the charity.


Medpace is a global full-service clinical research organization (CRO) providing Phase I-IV core development services for drug, biologic, and device programs. Medpace has strong experience supporting development programs across a number of therapeutic areas including oncology, cardiovascular, metabolic/diabetes, infectious disease, neuroscience, regenerative medicine, gastrointestinal diseases, pediatrics, and orphan disease. With extensive medical expertise, and renowned regulatory affairs department, Medpace employs 2000 employees and has clinical trial experience in over 45 countries and 6 regions – North America, Europe, Asia Pacific, Latin America, Africa, and the Middle East. From feasibility, research site compatibility, safety, and logistics, Medpace brings efficiencies and operational excellence to both drug and device development programs. In addition, Medpace offers integrated imaging, central and bioanalytical lab capabilities, and clinical pharmacology through wholly-owned business units to provide cohesive, streamlined, and standardized trial management.

For more information visit the Medpace website at: